首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

2008076

新生牛血清市场：按产地、应用、最终用户和地区划分

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年新生牛血清市场规模估计为2.899亿美元，预计2033年将达到4.594亿美元。预计2026年至2033年，该市场将以6.8%的复合年增长率成长。

报告范围		报告详情
基准年：	2025	2026年市场规模：	2.899亿美元
业绩数据週期：	2020-2024	预测期：	2026-2033
2026-2033年预测期间的复合年增长率：	6.80%	2033年市场规模预测：	4.594亿美元

新生牛血清是从20日龄以下健康屠宰牛的牛中提取的液体部分，经证实适合人类食用。它广泛应用于工业和学术研究，是细胞培养中常用的基础培养基添加剂之一，在干细胞研究以及兽用和人类疫苗的研发中发挥重要作用。

牛和新生牛血清通用许多相同的营养成分，但新生牛血清中白蛋白和球蛋白等蛋白质含量相对较高。 14日龄以下的健康牛在严格的采集和处理标准下进行检测，用于生产新生牛血清。新生牛血清可应用于生物技术研发、干细胞研究、克隆技术、动物诊断、体外受精、生物製药、基因疗法和合成蛋白等领域。

市场动态

市场企业间为拓展业务组合而加强合作，预计将推动全球新生牛血清市场成长。例如，2022年6月28日，医疗科技公司泰尔茂血液与细胞科技公司（Terumo Blood and Cell Technologies）与製药公司GenCure达成合作，旨在拓展其细胞和基因疗法的生产解决方案。此次合作将充分利用泰尔茂和GenCure的专业技术，在BioBridge Global建立一个参考製造地，为全球客户提供广泛的血液、细胞和组织产品。透过此参考生产基地，GenCure将为细胞和基因疗法的研发人员提供解决方案。细胞培养技术应用于细胞和基因疗法，而新生牛血清则用于培养各种细胞株。

市场相关人员正转向先进的细胞生产技术，预计将推动全球新生牛血清市场的成长。例如，2017年，非营利组织MaRS旗下的先进治疗细胞技术中心（CATCT）确定了先进的生产解决方案，以实现细胞生产流程的产业化，从而满足全球细胞治疗公司的需求。新生牛血清是Vero细胞株培养的关键成分，随着细胞生产技术的进步，其使用量预计将会增加。

众多市场参与企业积极参与各类会议，共同探讨细胞株和细胞培养技术的快速发展，预计将推动全球新生牛血清市场的成长。例如，在2021年举行的美国西部生物工艺国际会议（线上举行）上，与会者重点讨论了不同培养基中细胞株的稳定性以及细胞株开发的快速增长。会议强调提高市场相关人员对细胞培养技术的认识，预计将增加牛血清在市场上的使用量。

本次调查的主要特点。

本报告对预测期（2022-2030 年）内全球新生牛血清市场规模进行了详细分析，以 2021 年为基准年。
本报告指出了各个细分市场的潜在商机，并说明了该市场中具有吸引力的投资提案矩阵。
此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、区域前景以及主要企业采取的竞争策略的重要见解。
本报告根据以下参数对全球新生牛血清市场的主要企业进行了分析：公司概况、财务表现、产品系列、地理分布、分销策略、关键发展和策略以及未来计划。
透过利用本报告中提出的见解，企业行销负责人和经营团队可以就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
这份全球新生牛血清市场报告旨在为行业内的各种相关人员提供参考，包括投资者、供应商、製造商、经销商、新参与企业和金融分析师。
透过分析全球新生牛血清市场的各种策略矩阵，相关人员将能够更轻鬆地做出决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
- 南非
- 中非
- 北非

第八章竞争情势

公司简介
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA.
- Corning Inc.
- Atlas Biologicals, Inc.
- TCS Biosciences Ltd.
- Bovogen Biologicals Tty Ltd.
- Novus Biologicals, LLC
- Capricorn Scientific
- PAN-Biotech GmbH
- Atlanta Biologicals, Inc.
- Rockey Mountain Biologicals
- GE Healthcare
- Serana
- Zhejiang Tianhang Biotechnology

第九章

参考
调查方法

简介目录

Product Code: CMI5331

Newborn Calf Serum Market is estimated to be valued at USD 289.9 Mn in 2026 and is expected to reach USD 459.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 289.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.80%	2033 Value Projection:	USD 459.4 Mn

Newborn calf serum is the liquid portion of clotted blood taken from healthy, slaughtered bovine calves younger than 20 days that have been confirmed to be suitable for human consumption. It is widely used in industrial and academic research. It is one of the supplements used as a basal growth medium in cell culture. It plays a major role in stem cell research and the research of veterinary and human vaccines.

Fetal bovine serum and newborn calf serum both contain many of the same nutrients; however, newborn calf serum contains relatively more protein such as albumin and globulins. Bovine calves which are under 14 days old and healthy are inspected and collected for the production of newborn calf serum under strict collection and processing criteria. Newborn calf serum has applications in biotechnology research and development, stem cell research, cloning, animal diagnostic, in vitro fertilization, biopharmaceuticals, gene therapy, synthetic proteins, etc.

Market Dynamics

Increasing collaboration among the market players in order to expand their portfolio is expected to drive the growth of the global newborn calf serum market. For instance, in June 28, 2022, Terumo Blood and Cell Technologies, a medical technology company, collaborated with GenCure, a pharmaceutical company, to expand their manufacturing solutions for cell and gene therapy. The collaboration will utilize expertise from Terumo and GenCure to form a reference manufacturing center for BioBridge Global, provide a wide range of blood, cell and tissue products to customers worldwide. Through this reference site, GenCure will deliver solution for cell and gene therapy developers. Cell and gene therapy uses cell culture techniques and new born calf serum is used for growing different cell lines.

Market players are moving towards advance cell manufacturing technologies, which is expected to drive the global newborn calf serum market growth. For instance, in 2017, the Centre for Advanced Therapeutic Cell Technologies (CATCT) at MaRS, a nonprofit corporation found advanced manufacturing solutions to industrialize the cell manufacturing process to meet the needs of cell therapy companies around the world. Newborn calf serum is key ingredient in growing Vero cell lines, the development of cell manufacturing will increase the use of newborn calf serum.

Conferences have been organized and market players are participating on a large scale for discussion and talking about the rapid development in cell line and cell culture, which is expected to drive the global newborn calf serum market growth. For instance, in 2021, BioProcess International U.S. West conference held virtual event, highlighted its presentation on cell lines stability with different media, boom in cell-line development etc., they focused on increasing the awareness among market players about cell culture techniques, through which it is expected the use of calf serum will increase in market.

Key features of the study

This report provides an in-depth analysis of the global newborn calf serum market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global newborn calf serum market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Corning Inc., Atlas Biologicals, Inc., TCS Biosciences Ltd., Bovogen Biologicals Pty Ltd., Novus Biologicals, LLC, Capricorn Scientific, PAN biotech, Atlanta Biologicals, Inc., Rockey Mountain Biologicals, GE Healthcare, Serana, and Zhejiang Tianhang Biotechnology.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global newborn calf serum market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global newborn calf serum market

Market Segmentation

Global Newborn Calf Serum Market, By Origin
- New Zealand Origin
- U.S. Origin
- Australia Origin
- Others (Brazil Origin, Mexico Origin, etc.)
Global Newborn Calf Serum Market, By Application
- Drug Discovery
- Cell Media Culture
- Others
Global Newborn Calf Serum Market, By End User
- Biotechnology & Pharmaceutical Industries
- Academic Institutes
- Others (Research labs and Diagnostic Labs, etc.)
Global Newborn Calf Serum Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Global Newborn Calf Serum Market, Key Player
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Corning Inc.
- Atlas Biologicals, Inc.
- TCS Biosciences Ltd.
- Bovogen Biologicals Pty Ltd.
- Novus Biologicals, LLC
- Capricorn Scientific
- PAN-Biotech GmbH
- Atlanta Biologicals, Inc.
- Rockey Mountain Biologicals
- GE Healthcare
- Serana
- Zhejiang Tianhang Biotechnology

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Origin
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
New Zealand Origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
U.S. Origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Australia origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others (Brazil Origin, Mexico Origin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Cell Media Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biotechnology and Pharmaceuticals industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Academics Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Other (Research labs and Diagnostic Labs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country/Region , 2026 - 2033 (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- HiMedia Laboratories
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sartorius AG
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Merck KGaA.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Corning Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Atlas Biologicals, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- TCS Biosciences Ltd.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Bovogen Biologicals Tty Ltd.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Novus Biologicals, LLC
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Capricorn Scientific
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- PAN-Biotech GmbH
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Atlanta Biologicals, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Rockey Mountain Biologicals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- GE Healthcare
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Serana
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Zhejiang Tianhang Biotechnology
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

新生牛血清市场：按产地、应用、最终用户和地区划分

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

市场动态

目录

第一章：研究目标与前提条件

第二章市场概览

第三章：市场动态、监管与趋势分析

第四章：全球新生牛血清市场：依产地划分，2026-2033年

第五章全球新生牛血清市场：依应用领域划分，2026-2033年

第六章全球新生牛血清市场：依最终用户划分，2026-2033年

第七章全球新生牛血清市场：依地区划分，2026-2033年

第八章竞争情势

第九章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

8. Competitive Landscape

9. Section

新生牛血清市场：按产地、应用、最终用户和地区划分

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

市场动态

目录

第一章：研究目标与前提条件

第二章 市场概览

第三章：市场动态、监管与趋势分析

第四章：全球新生牛血清市场：依产地划分，2026-2033年

第五章 全球新生牛血清市场：依应用领域划分，2026-2033年

第六章 全球新生牛血清市场：依最终用户划分，2026-2033年

第七章 全球新生牛血清市场：依地区划分，2026-2033年

第八章 竞争情势

第九章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

8. Competitive Landscape

9. Section

第二章市场概览

第五章全球新生牛血清市场：依应用领域划分，2026-2033年

第六章全球新生牛血清市场：依最终用户划分，2026-2033年

第七章全球新生牛血清市场：依地区划分，2026-2033年

第八章竞争情势